Rachel S. Evans

ICON Plc, Milton Park
Milton, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance.

An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance.

Journal: Cancers

Published: December 12, 2025

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Journal: Blood

Published: May 05, 2025

Technology Matters: Online Support and Intervention (OSI) for child anxiety problems - an example of the journey from research to practice.

Technology Matters: Online Support and Intervention (OSI) for child anxiety problems - an example of the journey from research to practice.

Journal: Child and adolescent mental health

Published: January 24, 2025

Mental Health and Personality Functioning of People With Probable Personality Disorder Who Have Coexisting Complex Post Traumatic Stress Disorder.

Mental Health and Personality Functioning of People With Probable Personality Disorder Who Have Coexisting Complex Post Traumatic Stress Disorder.

Journal: Personality and mental health

Published: October 25, 2024

Expert Opinions on an Optimal Infant Feeding Quantitative Data Framework: A Mixed Methods Delphi-Style Study in the UK.

Expert Opinions on an Optimal Infant Feeding Quantitative Data Framework: A Mixed Methods Delphi-Style Study in the UK.

Journal: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association

Published: August 19, 2024

Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.

Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.

Journal: Frontiers in oncology

Published: April 28, 2024

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

Journal: EMBO molecular medicine

Published: January 29, 2024

Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.

Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.

Journal: Advances in therapy

Published: December 18, 2023

Implementing and evaluating group interpersonal therapy for postnatal depression in Lebanon and Kenya-individually randomised superiority trial.

Implementing and evaluating group interpersonal therapy for postnatal depression in Lebanon and Kenya-individually randomised superiority trial.

Journal: Trials

Published: November 21, 2023

Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.

Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.

Journal: Journal of comparative effectiveness research

Published: August 29, 2023

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.

Journal: Frontiers in oncology

Published: July 12, 2023

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives.

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives.

Journal: Frontiers in endocrinology

Published: April 24, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026